FDA Releases Draft Guidance on Improving Communication of Safety Information through Dear Health Care Provider Letters

Summary

The Food and Drug Administration (FDA) has published a draft guidance document aimed at enhancing the quality of Dear Health Care Provider (DHCP) letters, which are used to inform physicians and healthcare providers about important safety information related to marketed drugs and biologics.